Temporal and spatial profile of polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs) in ischemic stroke in mice.
Animals
Antigens, Ly
/ metabolism
Bone Marrow Cells
/ cytology
Brain Ischemia
/ immunology
CD11b Antigen
/ metabolism
Cytokines
/ metabolism
Flow Cytometry
Male
Mice
Mice, Inbred C57BL
Myeloid-Derived Suppressor Cells
/ cytology
NADPH Oxidase 2
/ genetics
Neutrophils
/ cytology
Spleen
/ cytology
Transcription Factor CHOP
/ genetics
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2019
2019
Historique:
received:
17
12
2018
accepted:
02
04
2019
entrez:
4
5
2019
pubmed:
3
5
2019
medline:
10
1
2020
Statut:
epublish
Résumé
Although T cells play important roles in the pathophysiology of ischemic stroke, the dynamics of T cells remains unclear. In cancer, polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs) contribute to the maintenance of the tumor microenvironment by suppressing T cells. However, the presence of these cells has never been examined in ischemic brain. Therefore, we examined the temporal and spatial profiles of PMN-MDSCs, which are defined as the CD11b+Ly6ClowLy6G+ cells with higher expression levels of Nox2 and C/EBP Homologous Protein (CHOP) mRNA than normal neutrophil. Fluorescence-activated cell sorter (FACS) analysis showed that the count of CD11b+Ly6ClowLy6G+ cells was increased in the ischemic hemisphere and bone marrow at 72 hours, as well as in the spleen 24 hours after transient middle cerebral artery occlusion in mice. In contrast, the contralateral hemisphere, normal bone marrow, and normal spleen contained few CD11b+Ly6ClowLy6G+ cells. Real-time reverse transcription polymerase chain reaction revealed that CD11b+Ly6ClowLy6G+ cells sorted from brain and spleen 72 hours after ischemia had greater expression of Nox2 and CHOP mRNA than neutrophils in bone marrow, suggesting that these cells constitute PMN-MDSCs. Immunohistochemistry showed that CD11b+Ly6G+ cells were located in the ischemic core and border zone, indicating that PMN-MDSCs might be endemic to these regions. Although neutrophils are believed to invade infarct regions 48-72 hours after ischemia, the present study suggested that some of these cells are in fact PMN-MDSCs. Further studies on the function of PMN-MDSCs might unveil the unknown mechanisms of T cell activation and recruitment in ischemic stroke.
Identifiants
pubmed: 31048856
doi: 10.1371/journal.pone.0215482
pii: PONE-D-18-35919
pmc: PMC6497247
doi:
Substances chimiques
Antigens, Ly
0
CD11b Antigen
0
Cytokines
0
Ddit3 protein, mouse
0
Ly6G antigen, mouse
0
Transcription Factor CHOP
147336-12-7
Cybb protein, mouse
EC 1.6.3.-
NADPH Oxidase 2
EC 1.6.3.-
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0215482Déclaration de conflit d'intérêts
The Department of Health Development and Medicine is financially supported by AnGes and DAICEL. Munehisa Shimamura and Hironori Nakagami are stockholders of MH peptide. However, this does not alter our adherence to PLOS ONE policies on sharing data and materials.
Références
Oncotarget. 2015 May 20;6(14):12369-82
pubmed: 25869209
Semin Immunol. 2018 Feb;35:19-28
pubmed: 29254756
Blood. 2008 Apr 15;111(8):4233-44
pubmed: 18272812
J Cereb Blood Flow Metab. 1999 Nov;19(11):1256-62
pubmed: 10566972
Stroke. 1995 Jun;26(6):1093-100
pubmed: 7762028
J Immunol. 2009 May 1;182(9):5693-701
pubmed: 19380816
Proc Natl Acad Sci U S A. 2014 Jun 3;111(22):8191-6
pubmed: 24847069
Cell Rep. 2015 Jul 14;12(2):244-57
pubmed: 26146082
Trends Immunol. 2016 Mar;37(3):208-220
pubmed: 26858199
Nat Commun. 2016 Jul 06;7:12150
pubmed: 27381735
J Cereb Blood Flow Metab. 1995 Jan;15(1):42-51
pubmed: 7528223
Nat Rev Immunol. 2012 Mar 22;12(4):253-68
pubmed: 22437938
J Vis Exp. 2011 Feb 02;(48):
pubmed: 21339713
J Clin Invest. 2015 Sep;125(9):3356-64
pubmed: 26168215
J Immunol. 2008 Oct 15;181(8):5791-802
pubmed: 18832739
Nat Med. 2011 Jul 07;17(7):796-808
pubmed: 21738161
PLoS Pathog. 2011 Nov;7(11):e1002374
pubmed: 22102816
Nat Rev Immunol. 2009 Mar;9(3):162-74
pubmed: 19197294
Circulation. 2006 May 2;113(17):2105-12
pubmed: 16636173
Front Immunol. 2017 Feb 06;8:86
pubmed: 28220123
Neuroreport. 2014 Oct 1;25(14):1122-8
pubmed: 25089804
Immunology. 2014 Dec;143(4):512-9
pubmed: 25196648
Physiol Rev. 2007 Jan;87(1):245-313
pubmed: 17237347
J Immunol. 2010 Mar 15;184(6):3106-16
pubmed: 20142361
Cancer Immunol Res. 2015 Nov;3(11):1236-47
pubmed: 26025381
Glia. 1998 Dec;24(4):437-48
pubmed: 9814824
Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2491-6
pubmed: 22308361
Sci Rep. 2015 Dec 15;5:18217
pubmed: 26666576
J Clin Invest. 2014 Jun;124(6):2626-39
pubmed: 24789911
Nat Commun. 2013;4:2218
pubmed: 23887712
Gut. 2014 Nov;63(11):1769-81
pubmed: 24555999
Nat Rev Immunol. 2016 Oct;16(10):599-611
pubmed: 27526640
Brain Res. 2014 Oct 24;1586:184-92
pubmed: 25152468
Nat Med. 2009 Aug;15(8):946-50
pubmed: 19648929